You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cystic fibrosis

Mannitol dry powder for inhalation for treating cystic fibrosis

  • Technology appraisal guidance
  • Reference number: TA266
  • Published:  28 November 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Cystic fibrosis - mannitol: addendum to Evidence Review Group's Report following Pharmaxis' new evidence submission of 3rd July 2012

Cystic fibrosis - mannitol: addendum to Evidence Review Group's Report following Pharmaxis' new evidence submission of 3rd July 2012 Cystic fibrosis - mannitol: addendum to Evidence Review Group's Report following Pharmaxis' new evidence submission of 3rd July 2012
26 October 2012
(327.42 Kb 35 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 24 October 2012

Back to top